Aller au contenu principal
Accès ouvert déclaré 2026 article

Microcystic, elongated, and fragmented (MELF) pattern of myometrial invasion in grade 1–2 endometrioid endometrial carcinoma: clinicopathological associations, molecular profile, and prognostic significance under FIGO 2023 staging

0Citations signalées, ce qui n’est pas une note de qualité
2Institutions déclarées
1Pays d’affiliation déclarés

Rattachement africain : tr. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Background: The microcystic, elongated, and fragmented (MELF) pattern of myometrial invasion is a morphological feature of endometrioid endometrial carcinoma (EEC) with debated prognostic significance. Most prior studies evaluated MELF across heterogeneous histologic grades and predate the FIGO 2023 staging system. We assessed MELF prevalence in a uniform Grade 1-2 EEC cohort and its clinicopathological, molecular, and survival associations. Methods: We retrospectively reviewed 112 patients with Grade 1-2 EEC surgically treated at a tertiary center (2015-2023). MELF status was determined by pathology re-review, and molecular profiling used immunohistochemistry (IHC) for mismatch repair (MMR) proteins, p53, and hormone receptors. Associations were assessed with Fisher's exact and Mann-Whitney U tests; survival was analyzed by Kaplan-Meier, log-rank, and Cox regression with Firth penalization. Results: MELF was identified in 43/112 patients (38.4%). MELF-positive tumors were significantly associated with deep myometrial invasion (65.1% vs. 24.6%; OR 5.71, 95% CI 2.44-13.35), lymphovascular space invasion (LVSI: 58.1% vs. 11.6%; OR 10.59, 95% CI 4.01-27.95), cervical stromal invasion (32.6% vs. 10.1%; OR 4.28, 95% CI 1.55-11.82; all p ≤ 0.005), and larger tumor size (median 3.7 vs. 3.0 cm; p=0.015). MELF was not associated with deficient mismatch repair (OR 1.48, p=0.39) or p53 mutant-type expression (OR 0.96, p=1.00). At a median follow-up of 54.5 months (9 deaths), MELF-positive patients showed numerically worse overall survival that did not reach statistical significance (log-rank p=0.059). On Firth-penalized Cox regression, deep myometrial invasion was the only significant univariate predictor (HR 7.12, p=0.036); the MELF survival signal attenuated to near-unity when depth of invasion was added. Conclusions: In Grade 1-2 EEC, MELF is a frequent pattern (38.4%) that reliably flags aggressive local invasion, including cervical stromal invasion relevant to FIGO 2023 upstaging. Its survival association was largely shared with depth of myometrial invasion rather than independent of it; MELF is therefore best regarded as a morphological marker of an aggressive phenotype rather than an independent prognostic factor. Being independent of mismatch repair and p53 status, MELF may aid risk assessment within the presumed no-specific-molecular-profile (NSMP-like) subgroup. Routine pathological reporting of MELF can prompt assessment of depth of invasion and high-risk features.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Microcystic, elongated, and fragmented (MELF) pattern of myometrial invasion in grade 1–2 endometrioid endometrial carcinoma: clinicopathological associations, molecular profile, and prognostic significance under FIGO 2023 staging
Date Crossref
13/08/2026
Éditeur
Frontiers Media SA
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Dokuz Eylül University Department of Obstetrics and Gynecology pays non établi dans la notice
    Université ou école supérieure
  • Izmir Atatürk Eğitim ve Araştırma Hastanesi pays non établi dans la notice
    Établissement de santé
  • Izmir Ataturk Research and Training Hospital Department of Pathology pays non établi dans la notice
    Établissement de santé

Department of Obstetrics and Gynecology — Dokuz Eylül University, Izmir Atatürk Eğitim ve Araştırma Hastanesi et Department of Pathology — Izmir Ataturk Research and Training Hospital.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Endometrial and Cervical Cancer TreatmentsGynecological conditions and treatmentsEndometriosis Research and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.